Literature DB >> 1678363

The multidrug resistance phenotype in human cancer.

C Cordon-Cardo, J P O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1678363

Source DB:  PubMed          Journal:  Important Adv Oncol        ISSN： 0883-5896


× No keyword cloud information.
  4 in total

1.  Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro.

Authors:  E C Sha; M C Sha; S H Kaufmann
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 2.  Reverse transformation of multidrug-resistant cells.

Authors:  J L Biedler; B A Spengler
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

3.  Modified multiple drug resistance phenotype of Chinese hamster ovary cells selected with X-rays and vincristine versus X-rays only.

Authors:  S McClean; B T Hill
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

4.  Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapy.

Authors:  Emma S Guns; Tetyana Denyssevych; Ross Dixon; Marcel B Bally; Lawrence Mayer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Apr-Jun       Impact factor: 2.569
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.